These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 2427861)

  • 1. Effects of celiprolol in anesthetized dogs with reduced myocardial function.
    Wolf PS; Smith RD; Barrett JA; Pruss TP
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S97-8. PubMed ID: 2427861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The haemodynamic and myocardial contractile effects of celiprolol, atenolol and propranolol in mecamylamine-verapamil pretreated, anaesthetised dogs.
    Smith RD; Barrett JA; Wolf PS; Pruss TP
    Br J Clin Pract Suppl; 1985 Jun; 42():35-43. PubMed ID: 2864075
    [No Abstract]   [Full Text] [Related]  

  • 3. Evaluation of alpha-adrenergic cardiac stimulation in anesthetized dogs: can this play a role in propranolol insensitive cardiostimulatory effects of celiprolol.
    Jolly SR; Smith RD; Wolf PS; Russ TP
    Res Commun Chem Pathol Pharmacol; 1986 Dec; 54(3):339-54. PubMed ID: 2879327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Celiprolol: a positive inotropic beta-adrenoceptor blocking agent in conscious dogs.
    Nganele DM; DeLeonardis VM; Hintze TH
    Br J Pharmacol; 1988 Mar; 93(3):501-8. PubMed ID: 2897217
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical pharmacology of celiprolol: a cardioselective beta-adrenergic antagonist and mild vasodilator.
    Perrone MH; Barrett JA
    Am Heart J; 1991 Feb; 121(2 Pt 2):677-83. PubMed ID: 1671187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partial agonist activity of celiprolol, a cardioselective beta-antagonist.
    Ochi S; Nakazawa M; Kimura T; Nakagawa Y; Imai S
    Eur J Pharmacol; 1991 Feb; 194(1):1-5. PubMed ID: 1676370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Celiprolol: a new beta adrenoceptor antagonist with novel ancillary properties.
    Pruss TP; Khandwala A; Wolf PS; Grebow P; Wong L
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S29-32. PubMed ID: 2427849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Celiprolol, a potent cardioselective beta 1-adrenoceptor antagonist with mild alpha 2-adrenoceptor antagonist properties.
    Wolf PS; Pruss TP; Rand MJ; Smith RD; Mann WS; Romano DV
    J Hypertens Suppl; 1985 Dec; 3(3):S195-7. PubMed ID: 2908816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiprolol, a compound which attenuates myocardial acidosis and improves regional segmental function following ischemia in dogs: a comparison with propranolol.
    Barrett JA; Magistro AM; Smith RD; Pruss TP; Wolf PS
    Pharmacology; 1989; 39(1):1-10. PubMed ID: 2573907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pharmacological studies of celiprolol: III. Effects of celiprolol on the cardiovascular system and renal function, and its antiarrhythmic effects].
    Ochi S; Kimura Y; Matsuzaki T; Hayashi S; Motonaga A; Tanaka M; Fukui H; Yamazaki A; Matsumura K; Miura A
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):209-27. PubMed ID: 1973400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Intrinsic sympathomimetic action and its special features as demonstrated by the beta-1-receptor blocker celiprolol].
    Pittner H
    Wien Klin Wochenschr Suppl; 1985; 162():1-21. PubMed ID: 2861698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial agonist activity of celiprolol as assessed in conscious unrestrained dogs in comparison with those of pindolol and labetalol.
    Ishibashi T; Ohta H; Jin H; Mitomi A; Tatebe S; Nakazawa M; Imai S
    Arzneimittelforschung; 1989 Oct; 39(10):1225-8. PubMed ID: 2575385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiovascular depression by verapamil: reversal by glucagon and interactions with propranolol.
    Jolly SR; Kipnis JN; Lucchesi BR
    Pharmacology; 1987; 35(5):249-55. PubMed ID: 3423100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does the beta 1-adrenoceptor blocking agent celiprolol have alpha 2-adrenoceptor blocking properties?
    Pittner H
    Arch Int Pharmacodyn Ther; 1987 Feb; 285(2):199-210. PubMed ID: 2883946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Celiprolol does not protect against ventricular tachycardia or sudden death in the conscious canine: a comparison with pindolol in assessing the role of intrinsic sympathomimetic activity.
    Uprichard AC; Chi LG; Kitzen JM; Lynch JJ; Frye JW; Lucchesi BR
    J Pharmacol Exp Ther; 1989 Nov; 251(2):571-7. PubMed ID: 2572693
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial agonist activity of celiprolol.
    Tung LH; Jackman G; Campbell B; Louis S; Iakovidis D; Louis WJ
    J Cardiovasc Pharmacol; 1993 Mar; 21(3):484-8. PubMed ID: 7681512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celiprolol, a compound possessing weak alpha 2-adrenergic antagonist properties in the dog.
    Mann WS; Sales EF; Van Inwegen RG; Barrett JA; Smith RD; Wolf PS
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):53-71. PubMed ID: 2881519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute hemodynamic effects of celiprolol.
    Donaldson RM; Williams LA; Lee EH
    Am J Cardiol; 1988 Feb; 61(5):49C-51C. PubMed ID: 2963526
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antagonist and partial beta agonist properties of celiprolol in isolated rat cardiac tissue.
    Smith RD; Cobuzzi A; Wolf PS; Pruss TP
    Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):147-61. PubMed ID: 2870551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Celiprolol and the heart.
    Taylor SH
    Am J Cardiol; 1988 Feb; 61(5):34C-40C. PubMed ID: 2893532
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.